Breaking News
FONT-SIZE Plus   Neg
Share SHARE

CACI International Q2 Profit Rises; Lifts 2012 Earnings Outlook - Update

RELATED NEWS
Trade CACI now with 

Shares of CACI International Inc. (CACI) gained more than 3 percent in after-hours trading on Wednesday after the provider of professional services and information technology solutions reported a 24 percent increase in profit for the second quarter on higher revenues and also raised its earnings outlook for fiscal year 2012.

The Arlington, Virginia-based company's second-quarter net income increased to $41.06 million or $1.51 per share from $33.24 million or $1.08 per share in the prior-year quarter.

Pro forma adjusted net income rose to $54.45 million or $2.00 per share from $45.89 million or $1.48 per share in the year-ago period. On average, 16 analysts polled by Thomson Reuters expected earnings of $1.30 per share for the quarter. Analysts' estimates typically exclude one-time items.

Revenues for the quarter grew 12.2 percent to $973.24 million from $867.28 million in the same period last year, but missed analysts' consensus estimate of $952.78 million.

The revenue increase was driven primarily by higher volumes of intelligence, surveillance and reconnaissance; business systems and cyber-related work. Organic revenue rose 8.9 percent from last year.

Paul Cofoni, CACI's President and CEO, said, "Our record second quarter performance confirms CACI's strategy to align our solutions with the government's highest priorities in defense, intelligence, homeland security, and government transformation."

Cofoni added, "With record results in revenue, operating income, net income, and EPS, we continue to deliver on our financial goals of mid- to high-single-digit organic revenue growth, double-digit earnings growth, and strong cash flow."

Contract funding orders in the second quarter rose 17.4 percent from the year-ago period to $604.67 million. Funded backlog as at December 31, 2011 was $2.19 billion compared with $2.18 billion a year earlier. Total backlog at the end of the quarter was $8.0 billion, up from $7.45 billion at the end of the year-ago period.

Looking ahead to fiscal year 2012, CACI raised its earnings guidance range to $5.72 to $5.94 per share from the prior estimate of $5.55 to $5.80 per share. Analysts currently estimate earnings of $5.67 per share for the year.

The company maintained its outlook for full-year revenue in a range of $3.85 billion to $4.05 billion. Analysts estimate revenues of $3.92 billion for the year.

CACI closed Wednesday's trading at $58.93, up $0.24 or 0.41 percent on a volume of 887,400 shares. In after-hours, the stock further gained $2.04 or 3.46 percent to $60.97.

Register
To receive FREE breaking news email alerts for CACI International Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
With trading resuming following the long, holiday weekend, stocks showed a lack of direction throughout the trading session on Tuesday before ending the day mixed. The markets largely held on to the bulk of their recent gains. The Islamic State (IS), a Sunni extremist group previously known as Islamic State of Iraq and the Levant (ISIL), has released a video purporting to show the beheading of US journalist Steven Sotloff, media reports said Tuesday. According to reports, the video also showed a masked man threatening to execute a British man named David Haines. He also warned governments to stay away "this evil allian Less than a month after resigning from Congress, former House Majority Leader Eric Cantor, R-Virg., has made the move from Washington to Wall Street by joining boutique investment bank Moelis & Co. A statement from Moelis said Cantor will serve as Vice Chairman and Managing Director and also be elected to the company's Board of Directors.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.